The growing prevalence of cancer, increasing demand for targeted cancer therapies, and rising need for effective immunosuppressive treatments are supporting the growth of the Everolimus Market. Everolimus is an mTOR (mammalian target of rapamycin) inhibitor used in the treatment of several cancers, organ transplant rejection prevention, and selected conditions associated with abnormal cell...